About Braveheart Bio, Inc. (BRVE) data
Data as of August 14, 2026.
Braveheart Bio, Inc. (BRVE) has 847.77K shares sold short as of the latest FINRA settlement report on August 14, 2026. Short interest has increased by 100.00% compared with the prior settlement. At the current average daily volume, covering all open short positions would take about 1.30 days (days to cover).
Recent BRVE short interest history
| Settlement date | Short interest | Change | Days to cover |
|---|---|---|---|
| Aug 14, 2026 | 847,773 | 100.00% | 1.30 |
Full history, charts, and borrow-fee detail are on the BRVE short interest page.
Frequently asked questions
What is the current short interest in BRVE?
As of the latest FINRA settlement dated August 14, 2026, BRVE had approximately 847,773 shares sold short. Short interest data is reported by FINRA twice per month.
How much does it cost to short BRVE?
The latest borrow fee (cost to borrow) for BRVE is 13.32% per year, based on IBKR data. Fees can change throughout the trading day as shares are borrowed and returned.
What is the days to cover ratio for BRVE?
Days to cover for BRVE is approximately 1.30 days. This estimates how many trading days it would take short sellers to buy back all outstanding short shares at the current average daily volume.
Is BRVE a short squeeze candidate?
A squeeze needs shorts that are hard to close. BRVE trades about 650,680 shares a day and would take roughly 1.30 days to unwind current short positions, at a current borrow fee of 13.32%. Higher days-to-cover and a rising borrow fee together are the setup to watch; neither alone is enough.